XT
SUPN icon

XTX Topco’s Supernus Pharmaceuticals SUPN Stock Holding History

XTX Topco’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.32M Buy
+25,626
New +$1.3M 0.02% 1180
2025
Q4 		– Sell
-16,065
Closed -$768K – 3781
2025
Q3 		$768K Sell
16,065
-25,195
-61% -$1.01M 0.04% 748
2025
Q2 		$1.3M Buy
+41,260
New +$1.32M 0.05% 518
2025
Q1 		– Sell
-7,822
Closed -$283K – 3076
2024
Q4 		$283K Sell
7,822
-2,028
-21% -$71.4K 0.02% 1277
2024
Q3 		$307K Sell
9,850
-5,820
-37% -$182K 0.02% 1162
2024
Q2 		$419K Buy
+15,670
New +$454K 0.04% 748

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XTX Topco's SUPN Position: Q1 2026 in Review

XTX Topco opened a new position in Supernus Pharmaceuticals (SUPN) in Q1 2026: 25,626 shares worth $1.32M. The stake represents 0.02% of the portfolio and ranks #1180 among its holdings. This is a return to the name: XTX Topco previously reported a position in SUPN as recently as Q3 2025.

XTX Topco first reported a position in SUPN in Q2 2024 and has held it in 6 quarters since. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • XTX Topco held 25,626 shares of Supernus Pharmaceuticals worth $1.32M as of Q1 2026.
  • Supernus Pharmaceuticals was a new XTX Topco position in Q1 2026.
  • Supernus Pharmaceuticals made up 0.02% of XTX Topco's portfolio in Q1 2026, its #1180 holding.
  • XTX Topco first reported a position in Supernus Pharmaceuticals in Q2 2024 and has held it in 6 quarters since.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.